title: Pregabalin-induced hyperprolactinemia in a patient with fibromyalgia: A case report.
abstract: Several pharmacological and non-pharmacological modalities have been proposed for the treatment of fibromyalgia syndrome (FMS), a common rheumatic disease. Pregabalin is suggested as a first-step medication for FMS in the newest guidelines. Drowsiness, dizziness, and peripheral edema are well-known side effects of pregabalin; however, mastalgia is rarely seen. Presently described is a case of FMS in a patient who developed mastalgia and hyperprolactinemia (HPL) while taking pregabalin.
authors.affiliation: Department of Physical Medicine and Rehabilitation, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
authors.forename: Aslihan
authors.initials: A
authors.lastname: Taraktas
authors.affiliation: Department of Physical Medicine and Rehabilitation, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
authors.forename: Nilgun
authors.initials: N
authors.lastname: Mesci
authors.affiliation: Department of Physical Medicine and Rehabilitation, Gebze State Hospital, Kocaeli, Turkey.
authors.forename: Gulcan
authors.initials: G
authors.lastname: Ozturk
authors.affiliation: Department of Physical Medicine and Rehabilitation, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
authors.forename: Duygu Geler
authors.initials: DG
authors.lastname: Kulcu
authors.affiliation: Department of Physical Medicine and Rehabilitation, Yeditepe University Hospital, Istanbul, Turkey.
authors.forename: Ece
authors.initials: E
authors.lastname: Aydog
keywords: Fibromyalgia; hyperprolactinemia; neuropathic pain; pregabalin